GenomeWeb reports that the US Senate has passed a bill to reauthorize the FDA’s medical device user fee program, allowing the agency to collect an additional $308 million over 5 years to fund its regulatory activities and to take steps to modernize its review and approval processes.
This move signals the final vote on the FDA Safety and Innovation Act (S 3178), as members of the Senate and House of Representatives hammered out a final version of the bill in the past few days.
The bill is now on its way to the White House.
The Supreme Court is expected to issue its ruling very soon on the Patient Protection and Affordable Care Act.
Read the entire article in GenomeWeb.